General Information of Disease (ID: DISR0X2K)

Disease Name Hereditary motor and sensory neuropathy
Synonyms HMSN
Definition
A group of slowly progressive inherited disorders affecting motor and sensory peripheral nerves. Subtypes include HMSNs I-VII. HMSN I and II both refer to CHARCOT-MARIE-Tooth DISEASE. HMSN III refers to hypertrophic neuropathy of infancy. HMSN IV refers to REFSUM DISEASE. HMSN V refers to a condition marked by a hereditary motor and sensory neuropathy associated with spastic paraplegia (see SPASTIC PARAPLEGIA, HEREDITARY). HMSN VI refers to HMSN associated with an inherited optic atrophy (OPTIC ATROPHIES, HEREDITARY), and HMSN VII refers to HMSN associated with retinitis pigmentosa. (From Adams et al., Principles of Neurology, 6th ed, p1343)
Disease Hierarchy
DISSYRHC: Hereditary peripheral neuropathy
DISR0X2K: Hereditary motor and sensory neuropathy
Disease Identifiers
MONDO ID
MONDO_0015358
MESH ID
D015417
UMLS CUI
C0027888
MedGen ID
45066
SNOMED CT ID
398100001

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 8 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
RAB7A TTF6WAQ Limited Genetic Variation [1]
GJB1 TTSJIRP moderate Genetic Variation [2]
AMACR TTLN1AP Strong Biomarker [3]
LCAT TTGZ91P Strong Altered Expression [4]
RNMT TTG45HY Strong Genetic Variation [5]
SGCG TTSMT9W Strong Genetic Variation [6]
SLC12A6 TT8DFHE Strong Biomarker [7]
TRPV4 TTKP2SU Strong Genetic Variation [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DTT(s)
This Disease Is Related to 2 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
HINT1 DEWJATF Strong Genetic Variation [9]
HK1 DEDMAGE Strong Genetic Variation [10]
------------------------------------------------------------------------------------
This Disease Is Related to 27 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ATP13A2 OTKWBUGK Limited Genetic Variation [11]
DHTKD1 OTDQLSNT Limited Biomarker [12]
FA2H OT8HA13U Limited Genetic Variation [11]
LRSAM1 OTOKWR6C Limited Biomarker [13]
SBF2 OTBB8NO8 Limited Biomarker [14]
NDRG1 OTVO66BO moderate Biomarker [15]
BICD2 OTVJ03NZ Strong Genetic Variation [16]
COX6A1 OT77MV8G Strong Biomarker [17]
DCAF8 OT3VFSLG Strong Genetic Variation [18]
DNAJB2 OTZHPV5M Strong Genetic Variation [19]
DYNC1H1 OTD1KRKO Strong Biomarker [20]
FGD4 OTYXJQCW Strong Altered Expression [21]
FIG4 OT501PY9 Strong Biomarker [22]
GARS1 OT5B6R9Y Strong Biomarker [23]
GDAP1 OTQE1O25 Strong Biomarker [24]
KIF1B OTI1XQTO Strong Genetic Variation [25]
LMNA OT3SG7ZR Strong Biomarker [26]
MAD2L1BP OT2O2IUJ Strong Genetic Variation [25]
MFN2 OTPYN8A3 Strong Genetic Variation [27]
MTMR2 OTNCYGBP Strong Biomarker [28]
NEFL OTQESJV4 Strong Biomarker [29]
RFC1 OT3L5PK3 Strong Biomarker [30]
SACS OTZGXQ8A Strong Genetic Variation [31]
SH3TC2 OTJ6XY2A Strong Genetic Variation [32]
SPTLC1 OTN0Z98K Strong Genetic Variation [33]
TFG OT2KJENI Strong Genetic Variation [34]
EGR2 OTAVQ78J Definitive Biomarker [35]
------------------------------------------------------------------------------------
⏷ Show the Full List of 27 DOT(s)

References

1 Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2.J Neurol Sci. 2001 Feb 15;184(1):1-9. doi: 10.1016/s0022-510x(00)00497-4.
2 Three novel mutations in a group of Chinese patients with X-linked Charcot-Marie-Tooth disease.Clin Neurol Neurosurg. 2019 Sep;184:105430. doi: 10.1016/j.clineuro.2019.105430. Epub 2019 Jul 10.
3 Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet. 2000 Feb;24(2):188-91. doi: 10.1038/72861.
4 Lipid abnormalities in hereditary neuropathy. Part I. Serum non-polar lipids.J Neurol Sci. 1976 Oct;29(2-4):161-75. doi: 10.1016/0022-510x(76)90168-4.
5 Unilateral oculomotor palsy in Charcot-Marie-Tooth disease 1A (CMT 1A).Clin Neurol Neurosurg. 2017 Apr;155:20-21. doi: 10.1016/j.clineuro.2017.02.004. Epub 2017 Feb 13.
6 Carrier rates of four single-gene disorders in Croatian Bayash Roma.Genet Test Mol Biomarkers. 2014 Feb;18(2):83-7. doi: 10.1089/gtmb.2013.0323. Epub 2013 Nov 4.
7 Molecular insights into the normal operation, regulation, and multisystemic roles of K(+)-Cl(-) cotransporter 3 (KCC3).Am J Physiol Cell Physiol. 2017 Nov 1;313(5):C516-C532. doi: 10.1152/ajpcell.00106.2017. Epub 2017 Aug 16.
8 TRPV4-associated skeletal dysplasias. Am J Med Genet C Semin Med Genet. 2012 Aug 15;160C(3):190-204. doi: 10.1002/ajmg.c.31335. Epub 2012 Jul 12.
9 HINT1 gene pathogenic variants: the most common cause of recessive hereditary motor and sensory neuropathies in Russian patients.Mol Biol Rep. 2020 Feb;47(2):1331-1337. doi: 10.1007/s11033-019-05238-z. Epub 2019 Dec 17.
10 HSMNR belongs to the most frequent types of hereditary neuropathy in the Czech Republic and is twice more frequent than HMSNL.Clin Genet. 2016 Aug;90(2):161-5. doi: 10.1111/cge.12745. Epub 2016 Mar 4.
11 Genetic and phenotypic characterization of complex hereditary spastic paraplegia.Brain. 2016 Jul;139(Pt 7):1904-18. doi: 10.1093/brain/aww111. Epub 2016 May 23.
12 DHTKD1 Deficiency Causes Charcot-Marie-Tooth Disease in Mice.Mol Cell Biol. 2018 Jun 14;38(13):e00085-18. doi: 10.1128/MCB.00085-18. Print 2018 Jul 1.
13 Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease.Dis Model Mech. 2013 May;6(3):780-92. doi: 10.1242/dmm.010942. Epub 2013 Mar 8.
14 Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice.Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4916-21. doi: 10.1073/pnas.0800742105. Epub 2008 Mar 18.
15 HMSN Lom in 12 Czech patients, with one unusual case due to uniparental isodisomy of chromosome 8.J Hum Genet. 2017 Mar;62(3):431-435. doi: 10.1038/jhg.2016.148. Epub 2016 Dec 22.
16 BICD2 mutational analysis in hereditary spastic paraplegia and hereditary motor and sensory neuropathy.Muscle Nerve. 2019 Apr;59(4):484-486. doi: 10.1002/mus.26394. Epub 2018 Dec 21.
17 A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease. Am J Hum Genet. 2014 Sep 4;95(3):294-300. doi: 10.1016/j.ajhg.2014.07.013. Epub 2014 Aug 21.
18 Ubiquitin ligase defect by DCAF8 mutation causes HMSN2 with giant axons. Neurology. 2014 Mar 11;82(10):873-8. doi: 10.1212/WNL.0000000000000206. Epub 2014 Feb 5.
19 HSJ1-related hereditary neuropathies: novel mutations and extended clinical spectrum. Neurology. 2014 Nov 4;83(19):1726-32. doi: 10.1212/WNL.0000000000000966. Epub 2014 Oct 1.
20 A novel mouse model carrying a human cytoplasmic dynein mutation shows motor behavior deficits consistent with Charcot-Marie-Tooth type 2O disease.Sci Rep. 2018 Jan 29;8(1):1739. doi: 10.1038/s41598-018-20081-1.
21 Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer.BMC Cancer. 2018 Dec 17;18(1):1257. doi: 10.1186/s12885-018-5096-9.
22 Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration.Hum Mol Genet. 2012 Aug 15;21(16):3525-34. doi: 10.1093/hmg/dds179. Epub 2012 May 11.
23 Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.PLoS Genet. 2011 Dec;7(12):e1002399. doi: 10.1371/journal.pgen.1002399. Epub 2011 Dec 1.
24 Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy.PLoS Genet. 2015 Apr 10;11(4):e1005115. doi: 10.1371/journal.pgen.1005115. eCollection 2015 Apr.
25 Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).J Neurol Sci. 2009 Jun 15;281(1-2):113-5. doi: 10.1016/j.jns.2009.03.008. Epub 2009 Apr 3.
26 Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002 Mar;70(3):726-36. doi: 10.1086/339274. Epub 2002 Jan 17.
27 Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.Arch Neurol. 2009 Dec;66(12):1511-6. doi: 10.1001/archneurol.2009.284.
28 An animal model for Charcot-Marie-Tooth disease type 4B1.Hum Mol Genet. 2005 Dec 1;14(23):3685-95. doi: 10.1093/hmg/ddi400. Epub 2005 Oct 25.
29 Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.Hum Mol Genet. 2015 Apr 15;24(8):2163-74. doi: 10.1093/hmg/ddu736. Epub 2014 Dec 30.
30 Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019 Apr;51(4):649-658. doi: 10.1038/s41588-019-0372-4. Epub 2019 Mar 29.
31 SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.Hum Genet. 2018 Dec;137(11-12):911-919. doi: 10.1007/s00439-018-1952-6. Epub 2018 Nov 21.
32 Genetics of the Charcot-Marie-Tooth disease in the Spanish Gypsy population: the hereditary motor and sensory neuropathy-Russe in depth.Clin Genet. 2013 Jun;83(6):565-70. doi: 10.1111/cge.12015. Epub 2012 Oct 10.
33 Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet. 2011 Jan 7;88(1):99-105. doi: 10.1016/j.ajhg.2010.12.003. Epub 2010 Dec 30.
34 Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation.Muscle Nerve. 2019 Dec;60(6):739-744. doi: 10.1002/mus.26683. Epub 2019 Aug 30.
35 Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.J Neurosci. 2009 Feb 25;29(8):2312-21. doi: 10.1523/JNEUROSCI.2168-08.2009.